PPARGC1A and Hyperglycemia: It also lowers PPARγ coactivator‐1α (PGC‐1α) expression, a transcription factor involved in mitochondria, which degrades mitochondrial function8 and generates metabolic syndrome in type 2 diabetic patients, including obesity, hyperglycemia, hyperlipidemia, and insulin resistance.